Volker Wiebking
- Aging top 5%
- Oncology top 5%
- CAR-T cell therapy research 5
- Genetics top 5%
- Virus-based gene therapy research 4
- Diabetes and associated disorders 1
- Molecular Biology top 10%
- CRISPR and Genetic Engineering 4
-
- Hematopoietic Stem Cell Transplantation 2
-
- Nitric Oxide and Endothelin Effects 1
-
- Cancer, Hypoxia, and Metabolism 1
-
- Acute Lymphoblastic Leukemia research 1
- Co-authors
- Matthew H. PorteusGang BaoCiaran M. LeeMara Pavel-DinuRasmus O. BakRolf TurkNatalia Gomez‐OspinaDaniel P. Dever
- Partner nations
- United StatesGermanyDenmark
In The Last Decade
Volker Wiebking
13 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Business and International Management 70
- Aging 48
- Oncology 501
- Genetics 371
- Molecular Biology 830
Countries citing papers authored by Volker Wiebking
This map shows the geographic impact of Volker Wiebking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volker Wiebking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volker Wiebking more than expected).
Fields of papers citing papers by Volker Wiebking
This network shows the impact of papers produced by Volker Wiebking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volker Wiebking. The network helps show where Volker Wiebking may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Volker Wiebking, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 14 | |
| 3 | Tuning the Antigen Density Requirement for CAR T-cell Activitybreakdown → | 2020 | 319 |
| 4 | 2020 | 32 | |
| 5 | 2020 | 53 | |
| 6 | 2019 | 135 | |
| 7 | 2018 | 14 | |
| 8 | A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsbreakdown → | 2018 | 541 |
| 9 | 2017 | 28 | |
| 10 | 2017 | 14 | |
| 11 | 2017 | 30 | |
| 12 | 2010 | 10 | |
| 13 | 2010 | 47 |
About Volker Wiebking
Volker Wiebking is a scholar working on Hematology, Oncology and Genetics, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Virus-based gene therapy research (4 papers), CRISPR and Genetic Engineering (4 papers), Hematopoietic Stem Cell Transplantation (2 papers), Diabetes and associated disorders (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Business and International Management (70 citations), Aging (48 citations) and Oncology (501 citations). Volker Wiebking has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Matthew H. Porteus, Gang Bao, Ciaran M. Lee, Mara Pavel-Dinu, Rasmus O. Bak, Rolf Turk, Natalia Gomez‐Ospina, Daniel P. Dever, Christopher A. Vakulskas and Shuqi Yan. Their work appears in journals such as Blood, Nature Medicine, Annals of Hematology, Bone Marrow Transplantation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.